Ligand validation:6EBS

ORO: OROTIC ACID

ORO is a Ligand Of Interest in 6EBS designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6EBS_ORO_A_402	82%	22%	0.085	0.941	1.08	2.12	-	4	0	0	100%	1
6EBS_ORO_B_402	70%	20%	0.103	0.92	1.1	2.26	-	4	0	0	100%	1
3GZ3_ORO_A_322	12%	30%	0.23	0.753	1.06	1.72	-	1	1	0	100%	1
3C61_ORO_B_501	4%	5%	0.317	0.71	1.54	3.72	2	5	0	0	100%	0.7
9DHH_ORO_A_402	100%	8%	0.025	0.992	1.58	3.05	2	2	0	0	100%	1
6FMD_ORO_A_411	100%	9%	0.034	0.992	1.02	3.42	1	2	0	0	100%	1
9DHI_ORO_A_402	100%	0%	0.032	0.99	2.36	6.63	2	4	0	0	100%	1
9DHJ_ORO_A_402	100%	1%	0.033	0.989	2.35	6.35	2	4	0	0	100%	1
5H73_ORO_A_403	100%	5%	0.035	0.989	2.56	2.79	5	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.